| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |